Difference between revisions of "Business Insights"
(new page) |
m (→Clients) |
||
| (One intermediate revision by the same user not shown) | |||
| Line 61: | Line 61: | ||
* [[Lipha]] | * [[Lipha]] | ||
* [[Lundbeck]] | * [[Lundbeck]] | ||
| − | * [[Merck]] | + | * [[Merck KGaA]] |
| − | * [[Merck | + | * [[Merck]] & Co. |
* [[Novartis]] | * [[Novartis]] | ||
* [[Novo Nordisk]] | * [[Novo Nordisk]] | ||
| Line 69: | Line 69: | ||
* [[Pharmacia and Upjohn]] | * [[Pharmacia and Upjohn]] | ||
* [[Pliva]] | * [[Pliva]] | ||
| − | * [[Procter | + | * [[Procter & Gamble]] |
* [[Ranbaxy]] | * [[Ranbaxy]] | ||
* [[Recordati]] | * [[Recordati]] | ||
* [[Rhône-Poulenc Rorer]] | * [[Rhône-Poulenc Rorer]] | ||
* [[Roche]] | * [[Roche]] | ||
| − | * [[Sanofi]] | + | * [[Sanofi]] (see [[Sanofi-Aventis]]) |
* [[Schering-Plough]] | * [[Schering-Plough]] | ||
* [[Schwarz]] | * [[Schwarz]] | ||
Latest revision as of 15:30, 12 February 2008
Background
Business Insights is a London based agency which provides market and company analysis services.
Their 'market analysis and forecasting explore all major issues, threats and opportunities' and provide businesses 'with incisive and actionable strategic recommendations'[1].
They advertise themselves [2] as delivering 'senior level business intelligence in a user-friendly format'. In doing so they focus on the following industries and areas of interest: consumer goods, energy, financial services, healthcare, technology, telecoms, eCommerce, Human Resources.
They go on to add[3] that 'No other market analysis company provides such focused and trusted market analysis, across such a wide range of industry sectors'.
Clients
Business Insights client list includes[4]...
- 3M
- Abbott Laboratories
- Affymetrix
- Agouron
- Allergan
- Alza
- Ares Serono
- Nycomed Amersham
- Amgen
- Andersen Consulting
- AstraZeneca
- BASF
- Bausch and Lomb
- Baxter
- Bayer
- Beaufour Ipsen
- BioChem Pharma
- Biochemie
- Biogal-Teva
- Biogen
- Boehringer Ingelheim
- Boots
- Bristol-Myers Squibb
- British Biotech
- Byk Gulden
- Cardinal Health
- Chiesi
- Chiron
- Chiroscience
- Chugai
- Daiichi
- Eisai
- Elan
- Eli Lilly
- Fournier
- Fujisawa
- Gehe
- Glaxo Wellcome
- Hoechst Marion Roussel
- Hoffman La Roche
- Immuno AG
- IPSEN
- Janssen
- Johnson & Johnson
- Knoll
- LEK
- Lipha
- Lundbeck
- Merck KGaA
- Merck & Co.
- Novartis
- Novo Nordisk
- Pfizer
- Pharmachemie
- Pharmacia and Upjohn
- Pliva
- Procter & Gamble
- Ranbaxy
- Recordati
- Rhône-Poulenc Rorer
- Roche
- Sanofi (see Sanofi-Aventis)
- Schering-Plough
- Schwarz
- Searle
- SmithKline Beecham
- Solvay
- Synthélabo
- Takeda
- Tanabe
- Teva
- Warner-Lambert
References
- ↑ Business Insights About Business Insights Accessed 5th February 2008
- ↑ Business Insights About Business Insights Accessed 5th February 2008
- ↑ Business Insights About Business Insights Accessed 5th February 2008
- ↑ Business Insights Patient Power: The shift towards more informed, more powerful consumers of drugs Accessed 5th February 2008
